Lutetium (177Lu) N.C.A Chloride

Radiopharmaceutical Precursor Solution

Used for the treatment of prostate cancer and neuroendocrine tumors.

Radiopharmaceutical Precursor Solution containing Lutetium (177Lu) Chloride and hydrochloric acid and water as excipients.

Radiopharmaceutical precursor. Not directly administered to the patient. This medicinal product is used only for labeling molecules suitable for labeling with Lu-177 radionuclide.

Calibration Activities
Guaranteed calibrated delivery every day of the week

The most important benefits:

  • Continuous supply of Lu-177 guaranteed due to cooperation with various nuclear reactors
  • Availability- on a weekly basis all year round
  • V Shaped for minimum material loss
  • Each lot is tested for labeling efficiency
Lutetium (177Lu) Chloride

Product Specifications

3 simple Steps: just define

Radionuclide177LU Lutetium Chloride Solution
Manufacturing DateEvery Friday
Packaging3 ml Type V, V Bottle, Glass Vial
10 ml Typ I, Flat Bottom Vial, Glass Vial
Half -life6,648 days
Chemical formLuCl3 in 0.05 HCI
Radiochemical Concentration37 GBq / mL
Radionuclide Purity≥ 99.9% Lutetium-177
≤ 0.07% Lutetium-177m
≤ 0.01% Other Impurities
Chemical PurityCu ≤ 1.0 μg/GBq
Fe ≤ 0.5 μg/GBq
Pb ≤ 0.5 μg/GBq
Zn ≤ 1.0 μg/GBq
Shelf life8 days after production